ReviewHarm reduction journal2024
Problematizing content moderation by social media platforms and its impact on digital harm reduction.
Review in Harm reduction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A Typology of Moderator Practices and Community Guidelines in Online Mental Health Communities to Establish a Framework for Digital Safety: Systematized Review.Journal of medical Internet research · 2026Review
- Social Media as a Driver of Obesity in Children and Adolescents (Aged 6-18 Years): It Is Time for Regulatory Action.Journal of medical Internet research · 2026Article
- Measuring Technology-Facilitated Sexual Violence and Abuse: Scoping Review of Existing Measures.Journal of medical Internet research · 2026Article
- Predatory marketing and false health promotion on social media: risk pathways in diet, fitness, and supplement communication.Frontiers in public health · 2026Article
- Co-creating harm reduction resources with young people who use nitrous oxide: What catches their attention?Harm reduction journal · 2025Article
- Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.Harm reduction journal · 2025Article
- Platforms, risk perceptions, and reporting: the impact of illicit drug advertisements on social media among UK secondary students.Harm reduction journal · 2025Article
- Digital transformation of the harm reduction sector-"Here4UScotland" a case study of a virtual supervised consumption.Digital healthArticle
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent years have marked a shift in selling and buying illicit psychoactive drugs from darknet cryptomarkets to publicly accessible social media and messaging platforms. As more users turn to procuring drugs this way, the role of digital harm reduction has become particularly urgent. However, one of the main obstacles complicating the implementation of digital harm reduction is the increasingly automated content moderation by the social media platforms. While some platforms are less restrictive about harm reduction content (e.g., TikTok), others implement higher degrees of moderation, including the removal of individual content and banning of entire profile pages (e.g., Instagram). This article discusses community guidelines of five popular social media and messaging platforms and their content moderation tools. It aims to highlight how these guidelines may be inadvertently curbing the dissemination of harm reduction and health promotion materials, and erroneously interpreting it as a promotion of drug use and sales. The discussion concludes that digital harm reduction requires transdisciplinary collaboration of professional organizations, researchers, and social media platforms to ensure reliable implementation of digital harm reduction, and help build safer digital communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.